Startups
We are global leaders in regenerative solutions. Our bioresorbable implant is trusted and widely use
Overview
Location
Australia, Western Australia, Perth
Employees
11-50
Phone
+65 6250 2817
Founded date
1992
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 21, 2025 | Researchers Develop 3D Printable Bio-Active Glass for Bone Repair | Researchers publishing in nonprofit organization ACS Nano have developed a 3D printable bio-active glass that could serve as an effective bone replacement material. In tests on rabbits, this material supported bone cell growth more effectiv... |
| Mar 18, 2025 | Unique 3D printed bioresorbable implants for patient-specific bone repair | Researchers at RWTH Aachen University’s Chair Digital Additive Production (DAP), working with the reACT alliance, are developing bioresorbable implants designed to fit each patient’s needs. The initiative is supported by the German Federal ... |
| Apr 8, 2023 | Australian Man Regrows Jaw Thanks to World-First Surgical Approach with 3D-printed Implant | Australian surgeons have performed a world-first surgical technique with a ground-breaking bioresorbable 3D-printed implant, which has led to the regeneration of a man’s jawbone. John Manwaring’s jawbone was originally reconstructed using a... |
| Dec 27, 2022 | Promising Singaporean Medtech Firm Osteopore Achieves Record Revenue, Enters New Markets and Operates in All Major Continents in 2022 | SINGAPORE, Dec. 27, 2022 /PRNewswire/ -- Singapore-based Medtech Firm Osteopore announces their record revenue of $460,684 for Q3 CY22, an increase of 6.6% over the preceding quarter. As an extension of the same financial year, Osteopore ha... |
| Nov 8, 2022 | Osteopore's Breakthrough Natural Tissue Regeneration Technology Leaps into Global Spotlight | The global leader's innovative regenerative medical technology and devices vastly improve patient outcomes and reduce overall medical costs. SINGAPORE, Nov. 8, 2022 /PRNewswire/ -- Osteopore International (ASX:OSX) ("Osteopore", &... |
| Dec 13, 2021 | BICO and Nanochon announce $1.5 million partnership to develop regenerative joint implants | 3D bioprinting firm BICO has announced an initial $1.5 million contract manufacturing deal with regenerative joint replacement start-up Nanochon. The deal will see Nanochon purchase products and services worth $1.5 million from BICO’s SCIEN... |
| Nov 9, 2021 | Regrowing Damaged Body Parts: How Osteopore, an Australian-listed Company, is Making it Accessible | SINGAPORE, Nov. 9, 2021 /PRNewswire/ -- Osteopore, an Australian and Singapore based leader in regenerative implants on a commercial scale, is developing technology that enables widespread adoption of tissue engineering. Despite the global ... |
| TANIOBIS Enables Patient-Specific Implants With Tantalum and Niobium Alloys | German materials company TANIOBIS is advancing its AMtrinsic powder range for use in additive manufacturing of medical implants, positioning tantalum and niobium alloys as a clinically superior alternative to the titanium standard that stil... |
Reviews 0
FAQ about Osteopore (OSX.AX)
When was Osteopore (OSX.AX) founded?
Osteopore (OSX.AX) was founded in 1992.
What has the press written about Osteopore (OSX.AX)?
Parsers VC has collected 9 articles mentioning Osteopore (OSX.AX), among them “Researchers Develop 3D Printable Bio-Active Glass for Bone Repair” (Oct 21, 2025) and “Unique 3D printed bioresorbable implants for patient-specific bone repair” (Mar 18, 2025).
Is Osteopore (OSX.AX) still active?
Yes, Osteopore (OSX.AX) is active; its latest activity on Parsers VC dates from Nov 4, 2025.